In humans, heterozygous point mutations in the glucokinase (GK) gene result in reduced enzymatic activity and decreased insulin secretion, causing maturity onset diabetes of the young (MODY) with early-onset and persistent hyperglycemia [6]. This evidence concerns the gene INS and type 2 diabetes mellitus.